Keywords: پیرفنیدون; Hermansky-Pudlak syndrome; pirfenidone; pulmonary fibrosis;
مقالات ISI پیرفنیدون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پیرفنیدون; Cornea; Neovascularization; Inflammation; Pirfenidone; Wound healing;
Keywords: پیرفنیدون; Pirfenidone; Paraquat; Lung injury; Fibrosis; Oxidative stress; Inflammation;
Keywords: پیرفنیدون; Gastric emptying; Idiopathic pulmonary fibrosis; Pharmacokinetics; Pirfenidone; AE; adverse event; AUC0-4h; area under the plasma concentration curve from 0 to 4â¯h; Cmax; maximum plasma concentration; CMC; carboxymethyl cellulose; GI; gastrointestina
Keywords: پیرفنیدون; Renal fibrosis; TGFβ; Pirfenidone; Endothelin-receptor A blockers; Galectin-3; Periostin; DDR1; CB1; miRNA; CKD; Biomarker; Collagen degradation products; Urinary exosomes; Targeted therapy;
Keywords: پیرفنیدون; Pirfenidone; Safety; Efficacy; Idiopathic Pulmonary Fibrosis; Severe;
Keywords: پیرفنیدون; Pirfenidone; Fibrosis; Antifibrotic; IPF; Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease; P38;
Keywords: پیرفنیدون; Acute exacerbation; Idiopathic pulmonary fibrosis; Pirfenidone; Recombinant human soluble thrombomodulin; Risk factors;
Keywords: پیرفنیدون; Non-small-cell lung cancer; Pirfenidone; TGF-β; Epithelial-mesenchymal transition; Chemoresistance;
Keywords: پیرفنیدون; Adherencias; Pirfenidona; Hialuronato de sodio/carboximetilcelulosaAdhesions; Pirfenidone; Sodium hyaluronate/carboxymethylcellulose
Keywords: پیرفنیدون; Adhesions; Pirfenidone; Sodium hyaluronate/carboxymethylcelluloseAdherencias; Pirfenidona; Hialuronato de sodio/carboximetilcelulosa
Keywords: پیرفنیدون; Clinical trial; connective tissue disease; hypersensitivity pneumonitis; idiopathic pulmonary fibrosis; interstitial lung disease; lung transplantation; nintedanib; pirfenidone; sarcoidosis
Keywords: پیرفنیدون; Focal adhesions; Matrix metalloproteinases; Matrix metalloproteinase inhibitors; Peritoneal fibrosis; Pirfenidone; Postoperative complications
Keywords: پیرفنیدون; Layer-by-layer films; Pirfenidone; Excisional wound healing; Collagen; TGF-beta expression
Keywords: پیرفنیدون; Pirfenidone; Fibrosis; Fibrotic nodules; Duchenne muscle dystrophy;
Keywords: پیرفنیدون; Pirfenidone; Caustic esophageal stenosis; RT-PCR; Fibrogenic esophageal stenosis; Sirius-red stain
Keywords: پیرفنیدون; Subarachnoid hemorrhage; Drug delivery; Pirfenidone; Graphene;
Keywords: پیرفنیدون; Fibrosis pulmonar; diagnóstico de fibrosis; tratamiento de fibrosis pulmonar idiopática; Pirfenidona; Nintedanib.Pulmonary fibrosis; diagnosis; treatment; idiopathic pulmonary fibrosis; Pirfenidone; Nintendanib.
Keywords: پیرفنیدون; Pirfenidone; Derivatives; Antifibrotic; IPF; p38;
Keywords: پیرفنیدون; Pirfenidone (Pub Chem CID: 40632); Rapamycin (Pub Chem CID: 5284616); Zotarolimus (Pub Chem CID: 23375907); Everolimus (Pub Chem CID: 6442177); Paclitaxel (Pub Chem CID: 441276); Pirfenidone; Zotarolimus; Everolimus; Rapamycin;
Keywords: پیرفنیدون; IPF; Idiopathic pulmonary fibrosis; JRS; Japanese Respiratory Society; SLB; surgical lung biopsy; VC; vital capacity; NHO-KCCMC; National Hospital Organization Kinki-Chuo Chest Medical Center; UIP; usual interstitial pneumonia; HRCT; high-resolution compu
Keywords: پیرفنیدون; Pirfenidone; Cough reflex sensitivity; Idiopathic pulmonary fibrosis; Neutral endopeptidase; Prostaglandin E2; Substance P;
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Pirfenidone; Clinical trial; Clinical practice
Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway
Keywords: پیرفنیدون; Pirfenidone, PubChem CID: 40632; Pirfenidone; Intestinal fibrosis; Intestinal fibroblasts; Proliferation; Fibrogenic activity;
Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy
Keywords: پیرفنیدون; ACR; albumin-to-creatinine ratio; AUC0-t; area under the curve; BuOH; n-butanol; BUN; blood urea nitrogen; Cmax; peak concentration; C13-NMR; C13-nuclear magnetic resonance; CCr; creatinine clearance rate; CCR2; CCchemkin receptor 2; CDCl3; Deuterotrichlo
Severe idiopathic pulmonary fibrosis: A clinical approach
Keywords: پیرفنیدون; IPF; idiopathic pulmonary fibrosis; UIP; Usual Interstitial Pneumonia; FVC; Forced Vital Capacity; SVC; Slow Vital Capacity; FEV1; Forced Expiratory Volume in the first second; TLC; Total Lung Capacity; RV; Residual Volume; DLCO; Diffusing Capacity of the
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design
Keywords: پیرفنیدون; 6-Minute walk test; Clinical trial; Echocardiogram; Hypertension; Idiopathic pulmonary fibrosis; Phosphodiesterase-5 inhibitor; Pirfenidone; Sildenafil;
Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
Keywords: پیرفنیدون; lung transplantation; idiopathic pulmonary fibrosis; anti-fibrotic therapy; pirfenidone; nintedanib; post-operative complications;
Synthesis and photophysical properties of deuteration of pirfenidone
Keywords: پیرفنیدون; Pirfenidone; Isotope deuterium; Negative solvatochrom; Density functional theory; Metal ions; Human serum albumin;
Synthesis and characterization of a non-cytotoxic and biocompatible acrylamide grafted pullulan - Application in pH responsive controlled drug delivery
Keywords: پیرفنیدون; PFD; Pirfenidone; Aam-g-pull; Acrylamide grafted pullulan; MTT; 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide; UV-vis; Ultraviolet-visible; DMSO; Dimethyl sulfoxide; OFW; Ozawa-Flynn-Wall; KAS; Kissinger-Akahira-Sunose; Pullulan; pH respo
Idiopathic pleuroparenchymal fibroelastosis (PPFE) - A case study of a rare entity
Keywords: پیرفنیدون; Idiopathic pleuroparenchymal fibroelastosis; Pirfenidone; Rare lung disease;
The effects of pirfenidone on T helper cells in prevention of intraperitoneal adhesions
Keywords: پیرفنیدون; Adhesion; Pirfenidone; Th1; Th2; Treg;
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Interstitial lung disease; Nintedanib; Pirfenidone;
SEPAR's voiceGuidelines for the Medical Treatment of Idiopathic Pulmonary FibrosisNormativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Treatment; Pirfenidone; Nintedanib; Fibrosis pulmonar idiopática; Tratamiento; Pirfenidona; Nintedanib;
Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Pirfenidone; Biomarker; Surfactant protein D; Predictor; Prognosis; ALAT; Latin American Thoracic Association; ATS; American Thoracic Society; AUC; area under the curve; CI; confidence interval; DLCO; diffusion capacity for
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Pirfenidone; Nintedanib; TOMORROW; INPULSIS; Diagnosis;
Modulating angiogenesis with integrin-targeted nanomedicines
Keywords: پیرفنیدون; (RGD)m; RGD mimetics; 4-NQO; 4-nitroquinoline 1-oxide; AAA; Abdominal Aortic Aneurysms; ADA; 8-Amino-3,6-Dioxaoctonoic Acid; AH-GDM; Aminohexyl-Geldanamycin; ami; Amide; AP-2α; Activating Protein 2α; ARMS; Alveolar Rhabdomyosarcoma; ATO; Arsenic Trioxid
Idiopathic pulmonary fibrosis: Physicians' perceptions of patient treatment with recently approved drugs
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis (IPF); Pirfenidone; Nintedanib; IPF disease severity
Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model
Keywords: پیرفنیدون; Pirfenidone; Inflammatory bowel disease; Intestinal fibrosis; Antifibrotic therapy;
Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC–MS/MS
Keywords: پیرفنیدون; Pirfenidone; UPLC–MS/MS; Rat plasma; Pharmacokinetics
Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy
Keywords: پیرفنیدون; Radiotherapy; Sunitinib; Pirfenidone; Lewis lung carcinoma; Transforming growth factor-β
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study
Keywords: پیرفنیدون; IPF; Pirfenidone; Therapy; AE; acute exacerbation; ATS; American Thoracic Society; EMA; European Medicine Agency; ERS; European Respiratory Society; DLCO; carbon monoxide diffusing capacity; FVC; forced vital capacity; IPF; idiopathic pulmonary fibrosis;
Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
Keywords: پیرفنیدون; Clinical trials; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Therapy; Treatment; AE; acute exacerbation; AEC; alveolar epithelial cell; ANCOVA; analysis of covariance; DLCO; diffusing capacity of the lung for carbon monoxide; DPLD; diffuse par
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Pirfenidone; Post-marketing surveillance; Safety
XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
Keywords: پیرفنیدون; Pirfenidone; Cell division cycle 7; Smads; Proliferation; Differentiation
Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
Keywords: پیرفنیدون; Pirfenidone; IPF; Lung fibroblasts; Proliferation; Fibrogenic activity
CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
Keywords: پیرفنیدون; Lung; Lung disease; Computed tomography; Idiopathic pulmonary fibrosis; Pirfenidone;
Management of idiopathic pulmonary fibrosis in France: A survey of 1244 pulmonologists
Keywords: پیرفنیدون; Idiopathic pulmonary fibrosis; Survey; Management; Drug therapy; Pirfenidone;
Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis
Keywords: پیرفنیدون; Renal fibrosis; Proteinuria; Pirfenidone; Podocyte; Glomerular injury
Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
Keywords: پیرفنیدون; Diffusion capacity of the lung for carbon monoxide; Forced vital capacity; Idiopathic pulmonary fibrosis; Interstitial pneumonia; Lung function test; Pirfenidone;